Navigation Links
Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Date:8/26/2008

he safety data are still blinded pending complete safety follow-up, there have been no serious adverse events reported. An independent external Data and Safety Monitoring Board fully supported continuation of the study including expansion to the 90 mcg dose.

VLPs are recombinant structures mimicking the size and shape of the virus but lack genetic material and are therefore incapable of replication. Because they resemble actual infectious particles presenting proteins in the same conformation as on the wild-type virus, they are able to induce a potent immune response. The HA and NA are included to induce neutralizing antibody responses, whereas the M1 may induce cell-mediated immune responses that provide protection against drifted (i.e., mutated) strains.

Addressing the Gaps in the System

"These data are exciting because they demonstrate that recombinant VLPs are a valid and potent vaccine approach against influenza. Combined with our innovative manufacturing approach, our VLP vaccine candidate has the potential to address an unmet need in pandemic influenza preparedness efforts being planned by health authorities around the world," said Dr. Rahul Singhvi, President and CEO of Novavax.

Novavax's manufacturing process makes it possible to potentially produce and distribute a vaccine matched to a pandemic strain in time to interrupt and/or halt a pandemic. Novavax's influenza VLPs are produced in insect cell culture, utilizing a manufacturing process that consists entirely of disposable, ready-to-use equipment. Current yields are 7 to 10 times higher than that of traditional egg-based or mammalian cell culture manufacturing. Because the Novavax process involves recombinant technology and does not require a live influenza virus, vaccine can be manufactured within 10 to 12 weeks of identification of a pandemic strain, approximately 50% of the time duration required to manufacture egg-based vaccines. As a key commercialization initiative, Nov
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
2. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
3. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
4. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
5. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
6. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
7. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
8. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
9. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
10. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
11. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a critical ... adsorber to reduce deadly inflammation in critically-ill and ... net of transaction costs, in non-dilutive funding as ... Certificate Transfer Program sponsored by the New Jersey ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... and development company, is delighted to announce that the ... to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for the ...
(Date:1/22/2015)... 2015  BiOptix is pleased to announce the appointment of ... Chemistry and Biochemistry. Scott joins the company after previous scientific ... throughout the course of his nearly 20 year career ... a nationally recognized thought leader in the biosensor field ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... Research, Advocacy and New Treatments , , ... May 11 The National Organization for Rare Disorders (NORD) will honor two trailblazing ... market for rare diseases at the 2010 NORD Partners in Progress Gala at the Andrew ... , , ...
... , MELBOURNE, Fla. , May 11 ... Therapeutics Corporation announced today the successful launch of its ... was selected to provide cardiac monitoring equipment by CNES, ... biomedical products. Cardiomed will utilize Medicomp,s durable Decipher Holter ...
Cached Medicine Technology:NORD to Honor Rare Disease Innovators 2NORD to Honor Rare Disease Innovators 3NORD to Honor Rare Disease Innovators 4Medicomp's Decipher Holter Monitor Provides Cardiac Reporting on the International Space Station 2Medicomp's Decipher Holter Monitor Provides Cardiac Reporting on the International Space Station 3
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
(Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
(Date:1/22/2015)... 2015 Four years since the release of their ... with the marriage of Avasa & Matthew Love – the duo ... scheduled for release through White Swan Records on February 24, 2015. ... a sacred path available to all of us to walk out ...
(Date:1/22/2015)... 2015 EBSCO Information Services (EBSCO) ... their relationship in an effort to further promote visibility and ... EBSCO has long made AMA journals available via its subscription ... The JAMA Network. , Long known as both ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... survivors address issues of sexual dysfunction with their patients, ... (MGH) researchers. In their article appearing in a ... of General Internal Medicine , now available online, the ... to a survey indicated they rarely or never discussed ...
... continue to push for progress , WEDNESDAY, Oct. 21 ... levels,a new report shows. , A record number of vaccines ... and more than 80 new vaccines are in late-stage clinical ... by the World Health Organization, UNICEF and the World Bank. ...
... ... ... the new report on the state of the world,s vaccines and immunization launched by the ... exactly what the United Nations Foundation strives to achieve. As a proud ...
... to Support Minimally Invasive Treatment in Those With Blocked Leg ... Vascular and Interventional Radiology , FAIRFAX, Va., Oct. ... PAD) -- with healthy lifestyle changes -- remains vital to ... Journal of Vascular and Interventional Radiology. And while PAD can ...
... attest, high school can be filled with difficult challenges, both ... prom or filling out college applications, stress can be high ... Va., native Dalton Clark, a challenge beyond his imagination emerged ... and suddenly, typical high school hurdles paled in comparison. ...
... University of Nottingham say our stress levels at work peak when ... as we head towards retirement. In the first comprehensive ... carried out in Britain researchers from the Institute of Work, Health ... working lives can stay with us well into retirement. The ...
Cached Medicine News:Health News:Sexual problems rarely addressed by internists caring for cancer survivors 2Health News:Worldwide Vaccine Availability Reaches All-Time High: Report 2Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation on the Launch of the State of the World's Vaccines and Immunization Report 2Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation on the Launch of the State of the World's Vaccines and Immunization Report 3Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 2Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 3Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 4Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 5Health News:'Inspired by Diabetes' U.S. National Contest Winners Reveal Unique Challenges but Common Resolve in the Face of Diabetes 2Health News:'Inspired by Diabetes' U.S. National Contest Winners Reveal Unique Challenges but Common Resolve in the Face of Diabetes 3Health News:'Inspired by Diabetes' U.S. National Contest Winners Reveal Unique Challenges but Common Resolve in the Face of Diabetes 4Health News:'Inspired by Diabetes' U.S. National Contest Winners Reveal Unique Challenges but Common Resolve in the Face of Diabetes 5Health News:'Inspired by Diabetes' U.S. National Contest Winners Reveal Unique Challenges but Common Resolve in the Face of Diabetes 6Health News:Older workers are the healthy 'survivors' of the workplace 2
... Hemaway Original attacks dried blood, tissue, ... in hard to reach places such as ... reducing the need for scrubbing. Hemaway Original ... but gentle enough to be used everyday. ...
... Hemaway Enzymatic Foam is the ready-to-use, pre-cleaning ... and rubber. ,Hemaway Enzymatic Foam ... prevent corrosion. It's perfect for use in ... immediately available. Getting a head start with ...
... Duo-Klenz is the low-foaming detergent and ... cycle of pressurized washers. Duo-Klenz ... medical and surgical instruments. Highly concentrated, ... while safely lubricating surgical instruments -- all ...
... Traps grip the patients finger snugly. Wrap the ... Stainless Steel Finger Trap for an extra secure ... traps create a complete upper extremity traction system ... ISI Advanced Universal K Table. Stainless Steel Finger ...
Medicine Products: